InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Reardon Tighe, 首席财务官. Officer active across 1 company, notably Janux Therapeutics, Inc.. In total, 3 filings have been logged. Split: 1 buy · 1 sell. Total volume traded: €11.3m. History available since 13 November 2023. The latest transaction was disclosed on 3 June 2024 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Tighe Reardon serves as the Acting Chief Financial Officer at Janux Therapeutics, Inc. He is responsible for overseeing the company's financial operations, including budgeting and financial analysis. His expertise contributes to the effective management of financial resources and strategic decision-making.